CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,688,348 | -27.5% | 180,305 | -46.8% | 1.24% | -26.7% |
| Q2 2023 | $3,710,320 | +22.3% | 338,842 | -2.6% | 1.70% | -31.3% |
| Q1 2023 | $3,032,694 | +22.3% | 347,786 | -12.0% | 2.47% | +67.9% |
| Q4 2022 | $2,478,732 | +79.1% | 395,332 | 0.0% | 1.47% | +86.2% |
| Q3 2022 | $1,384,000 | +18.7% | 395,332 | 0.0% | 0.79% | +12.2% |
| Q2 2022 | $1,166,000 | +80.8% | 395,332 | +90.7% | 0.70% | +71.7% |
| Q1 2022 | $645,000 | -3.6% | 207,307 | +77.9% | 0.41% | -4.0% |
| Q4 2020 | $669,000 | – | 116,519 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
| Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
| Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
| Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
| Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
| DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
| Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
| Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
| NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
| Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |